Funding for this research was provided by:
Forskningsrådet om Hälsa, Arbetsliv och Välfärd (2016-07113)
Received: 19 September 2017
Accepted: 29 December 2017
First Online: 14 February 2018
Ethics approval and consent to participate
: The trial has been approved by the Regional Ethics Committee (Regionala Etikprovninsnämnden, EPN), Stockholm; DNR: 2017/1380-31, and prospectively registered with German Clinical Trials Register on 14 July 2017: DRKS00012311 (ExternalRef removed). Informed consent will be obtained from all participants prior to inclusion. All patients must agree to participate voluntarily and will be free to withdraw from the study at any time. Patients randomized to exercise who wish to withdraw will be removed from the trial and offered usual care by a clinician. All participant data will be kept in a secure room accessible only by research personnel. The study protocol is publicly available via the institution’s website: (ExternalRef removed)Trial status: the trial is due to commence in January 2018.Protocol version 1, 28 November 2017.
: No individual-level participant data will be presented in scientific papers.
: The authors declare that they have no competing interests.
: Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.